Pet clinics文章索引

Cost Effectiveness of Positron Emission Tomography for Characterizing Pulmonary Nodules [0.03%] 正电子发射断层扫描对肺结节特征鉴别效果的成本效益分析

Michael K Gould Michael K Gould

PET clinics. 2006 Oct;1(4):339-46. DOI:10.1016/j.cpet.2006.10.001 2006

Evaluation of Cost-effectiveness of FDG-PET in Non-Small Cell Lung Cancer [0.03%] 非小细胞肺癌诊疗中的氟脱氧葡萄糖正电子发射断层扫描的成本效益分析研究进展

Otto S Hoekstra,Harm van Tinteren,Egbert F Smit Otto S Hoekstra

PET clinics. 2006 Oct;1(4):329-37. DOI:10.1016/j.cpet.2006.09.003 2006

Impact of PET on Radiation Therapy Planning [0.03%] PET对放射治疗计划的影响

Michael P Mac Manus,Rodney J Hicks Michael P Mac Manus

PET clinics. 2006 Oct;1(4):317-28. DOI:10.1016/j.cpet.2006.09.002 2006

Staging of Lung Cancer [0.03%] 肺癌的临床分期

Jokke Wynants,Sigrid Stroobants,Christophe Dooms et al. Jokke Wynants et al.

PET clinics. 2006 Oct;1(4):301-16. DOI:10.1016/j.cpet.2006.10.002 2006

Diagnosis of Lung Cancer: Perspective of a Pulmonary Radiologist [0.03%] 肺部肿瘤诊断：放射科医生的视角

Shawn D Teague,Dewey J Conces Jr Shawn D Teague

PET clinics. 2006 Oct;1(4):289-300. DOI:10.1016/j.cpet.2006.09.004 2006

Preface [0.03%] 前言

Andrew B Newberg,Abass Alavi Andrew B Newberg

Editorial PET clinics. 2010 Jan;5(1):xi-xii. DOI:10.1016/j.cpet.2010.03.002 2010

Imaging Pathophysiology and Neuroplasticity After Stroke [0.03%] 卒中后的影像病理生理和神经可塑性

James M Mountz James M Mountz

Use of imaging with the objective of improvement of stroke recovery should have a significant impact on determination of prognosis for recovery, which should assist patients and families in coping with the disabilities secondary to a stroke...

Review PET clinics. 2010 Jan;5(1):107-25. DOI:10.1016/j.cpet.2009.12.005 2010

PET in Cerebrovascular Disease [0.03%] 脑血管病的PET研究进展

William J Powers,Allyson R Zazulia William J Powers

Investigation of the interplay between the cerebral circulation and brain cellular function is fundamental to understanding both the pathophysiology and treatment of stroke. At present, PET is the only technique that provides accurate, quan...

Review PET clinics. 2010 Jan;5(1):83-106. DOI:10.1016/j.cpet.2009.12.007 2010

(18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons [0.03%] AV-133((18)F-AV-133)：一种选择性的VMAT2结合正电子放射性药物，用于多巴胺能神经元的PET成像

Franz F Hefti,Hank F Kung,Michael R Kilbourn et al. Franz F Hefti et al.

The early detection and monitoring of neurodegenerative diseases, including Parkinson disease, Alzheimer disease, dementia with Lewy bodies and other dementias, and movement disorders, represent a significant unmet medical need. Tools for a...

Review PET clinics. 2010 Jan;5(1):75-82. DOI:10.1016/j.cpet.2010.02.001 2010

SPECT and PET in Atypical Parkinsonism [0.03%] 特异型帕金森病的SPECT和PET检查

John P Seibyl John P Seibyl

Parkinson disease (PD) is the prototypic movement disorder originally described by James Parkinson, and it accounts for about 80% of a group of related degenerative motor disorders collectively referred to as the parkinsonisms, Parkinson sp...

Review PET clinics. 2010 Jan;5(1):65-74. DOI:10.1016/j.cpet.2010.02.005 2010